IT News פורטל המחשוב העסקי וההייטק של ישראל
Cellebrite (נאסד"ק: CLBT), מובילה עולמית בפתרונות בינה דיגיטלית (DI) למגזר הציבורי והפרטי, הודיעה היום כי תדווח על תוצאותיה הכספיות לרבעון הראשון של 2023 לפני פתיחת השוק ביום רביעי, 10 במאי 2023.
PETAH TIKVA, Israel and TYSONS CORNER, Va., April 11, 2023 (GLOBE NEWSWIRE):
Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced it will report its first-quarter 2023 financial results before market open on Wednesday, May 10, 2023.
Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter :of 2023 and discuss its full-year 2023 outlook. Pertinent details include:
| Date: | Wednesday, May 10, 2023 | |
| Time: | 8:30 a.m. ET | |
| Call-In Number: | 203-518-9814 | |
| Conference ID: | CLBTQ123 | |
| Event URL: | https://investors.cellebrite.com/events/event-details/cellebrite-q1-23-earnings | |
| Live Webcast URL: | https://edge.media-server.com/mmc/p/u58372yq |
In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results. A transcript of the call will be added to this page along with access to the replay of the call.
About Cellebrite
Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.
